J Frontier Co., Ltd. (2934) AI Stock Analysis

• Market Cap: ¥9.88B
• Dividend Yield: N/A
• Average Volume (3M): 24.26K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.20
• Revenue Growth: 31.42%
• EPS Growth: 34.01%
• Country: JP
• Employees: 315
• Sector: Healthcare
• Sector Strength: 37
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 5.55
• Shares Outstanding: 5,220,195
• 10 Day Avg. Volume: 28,030
• 30 Day Avg. Volume: 24,260
• PEG Ratio: -0.25
• Price to Book (P/B): 7.38
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,711.00
• Price Target Upside: -9.61% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 44 Neutral
• Price Target: ¥1,764.00 ▼(-6.81%Downside)

The stock's overall score is primarily impacted by its financial performance challenges, with significant profitability and cash flow issues. Despite some positive technical indicators suggesting short-term momentum, the poor valuation due to lack of profitability and dividends significantly lowers the score.

J Frontier Co., Ltd. Business Overview & Revenue Model

Company Description

J Frontier Co., Ltd. is a Japan-based company primarily engaged in the healthcare and beauty sectors. The company offers a range of products and services that include online medical consultations, health-related e-commerce, and other digital healthcare solutions. J Frontier Co., Ltd. leverages technology to bridge the gap between consumers and healthcare providers, facilitating access to medical and wellness products.

How the Company Makes Money

J Frontier Co., Ltd. generates revenue through multiple streams. Firstly, the company earns money from its e-commerce platform, which sells a variety of health and beauty products directly to consumers. Additionally, the company provides online medical consultation services, where it charges fees for virtual appointments and related healthcare services. The company also partners with healthcare providers and pharmaceutical companies to expand its service offerings and improve its product range. Furthermore, J Frontier Co., Ltd. may receive revenue from advertising or promotional partnerships on its platforms, contributing to its overall earnings.

J Frontier Co., Ltd. Financial Statement Overview

Summary

J Frontier Co., Ltd. shows revenue growth but faces profitability and cash flow challenges. Increasing leverage heightens financial risk, and negative cash flows suggest operational inefficiencies. Improvement in profitability and cash flow generation is critical for financial stability.

Income Statement

The company has shown revenue growth over the years, with a notable increase from 2022 to 2023. However, the profitability metrics such as EBIT and net income have been negative in recent years, indicating operational challenges. The gross profit margin has remained fairly stable, but negative EBIT and EBITDA margins suggest significant costs impacting earnings.

Balance Sheet

The debt-to-equity ratio has increased, indicating higher leverage, which poses a risk if earnings do not improve. Although the equity ratio has decreased, the company still maintains a positive stockholder equity, suggesting some balance sheet resilience. However, the declining ROE reflects inefficiencies in generating returns from equity.

Cash Flow

The company has struggled with negative operating and free cash flows, indicating cash generation issues. The free cash flow has not shown improvement, and the operating cash flow to net income ratio is negative, highlighting challenges in converting profits into cash. While financing activities have provided some relief, reliance on external funding is not sustainable long-term.

Breakdown	TTM	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	21.18B	17.71B	16.84B	11.88B	8.49B	7.11B
Gross Profit	9.55B	8.33B	7.12B	5.40B	6.63B	5.49B
EBITDA	-630.12M	-1.22B	-1.54B	760.66M	706.10M	237.16M
Net Income	-1.55B	-2.09B	-1.90B	400.52M	424.93M	96.37M
Balance Sheet
Total Assets	9.05B	10.71B	7.24B	6.10B	2.59B	2.03B
Cash, Cash Equivalents and Short-Term Investments	1.75B	1.81B	1.65B	2.96B	1.64B	908.06M
Total Debt	4.63B	5.17B	2.14B	546.79M	75.21M	168.86M
Total Liabilities	7.02B	9.09B	4.53B	1.94B	1.33B	1.19B
Stockholders Equity	1.26B	1.15B	2.48B	4.14B	1.27B	842.76M
Cash Flow
Free Cash Flow	0.00	-1.54B	-1.94B	-377.40M	823.99M	213.16M
Operating Cash Flow	0.00	-1.44B	-1.83B	-366.94M	830.91M	218.30M
Investing Cash Flow	0.00	-1.79B	-1.13B	-860.09M	-7.99M	-165.10M
Financing Cash Flow	0.00	3.39B	1.45B	2.56B	-93.65M	-99.10M

J Frontier Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1893.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2934, the sentiment is Positive. The current price of 1893 is above the 20-day moving average (MA) of 1811.10, above the 50-day MA of 1708.18, and above the 200-day MA of 1725.54, indicating a bullish trend. The MACD of 41.98 indicates Negative momentum. The RSI at 59.65 is Neutral, neither overbought nor oversold. The STOCH value of 68.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2934.

J Frontier Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3649	79 Outperform	¥19.11B	17.44		2.14%	12.51%	9.68%
3939	70 Outperform	¥20.77B	21.20		1.48%	17.20%	20.25%
4483	68 Neutral	¥258.30B	43.31		0.40%	28.85%	26.67%
4320	67 Neutral	¥11.13B	22.83		2.62%	9.21%	-20.04%
Sector *	64 Neutral	¥343.53B	10.93	-2.99%	2.55%	11.77%	-9.96%
2934	44 Neutral	¥9.88B	―		―	31.42%	34.01%
3902	43 Neutral	¥16.38B	4,465.71		1.55%	-7.98%	-181.00%